Z. S. ALTUN Et Al. , "The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma," PEDIATRIC BLOOD & CANCER , vol.64, 2017
ALTUN, Z. S. Et Al. 2017. The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma. PEDIATRIC BLOOD & CANCER , vol.64 .
ALTUN, Z. S., Ayla, M., Aktas, S., Pamukoglu, A., Ercetin, P., & Olgun, N., (2017). The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma. PEDIATRIC BLOOD & CANCER , vol.64.
ALTUN, ZEKİYE Et Al. "The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma," PEDIATRIC BLOOD & CANCER , vol.64, 2017
ALTUN, ZEKİYE S. Et Al. "The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma." PEDIATRIC BLOOD & CANCER , vol.64, 2017
ALTUN, Z. S. Et Al. (2017) . "The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma." PEDIATRIC BLOOD & CANCER , vol.64.
@article{article, author={ZEKİYE SULTAN ALTUN Et Al. }, title={The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma}, journal={PEDIATRIC BLOOD & CANCER}, year=2017}